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We have investigated the effect of lysophosphatidylcholine (LPC) on fusion of cells expressing the envelope glycoprotein
of HIV-1, gp120/gp41, with cells expressing the receptor for this virus, CD4. Fusion was inhibited by micromolar concentra-
tions of LPC added from an aqueous stock solution, but not by membrane-associated LPC or LPC produced in the
membrane by the action of phospholipase A2 . No inhibition was found for LPCs with acyl chain lengths shorter than 12
carbon atoms, and the inhibitory effect of longer molecules increased with their length. gp120-CD4 specific cell –cell
binding was inhibited with a chain length dependence corresponding to that of fusion, but with palmitoyl-LPC, fusion was
more strongly affected than binding. These data indicate that gp120/gp41-induced fusion is inhibited by LPC because
LPC affects viral protein –host cell binding and not because LPC prevented the formation of lipid intermediates required
for fusion. q 1997 Academic Press
INTRODUCTION tin, 1995), and the conformational changes induced upon
binding of gp120 to its receptor on the surface of the
Human immunodeficiency virus (HIV)2 enters cells by host cell (Allan, 1991; Moore et al., 1991; Sattentau et al.,
fusion of the viral membrane with the plasma membrane 1995) have been suggested to result in the exposure of
of the host cell, mediated by the HIV glycoprotein com- the fusion peptide (Larsen et al., 1992; Freed and Martin,
plex (Pelchen-Matthews et al., 1995; Larsen et al., 1992; 1995).
Moore et al., 1993; Freed and Martin, 1995). The complex Insertion of fusion peptides in the target membrane is
is composed of two noncovalently linked proteins, gp120 thought to create defects, leading to the formation of
and gp41 (Moore et al., 1993). The latter contains a C- transient intermediate lipid structures, such as stalks
terminal cytoplasmic tail and an ectodomain with a hy- (Chernomordik and Zimmerberg, 1995; Siegel, 1993a),
drophobic N-terminus, like the fusion proteins of ortho- and finally to the merger of the membranes (Siegel,
and paramyxoviruses (Freed et al., 1990; Gallaher, 1987). 1993b). Stalks are highly bent structures composed of
For example, the influenza virus fusion protein hemagglu- fused outer but unfused inner leaflets of the virus and
tinin (HA) is composed of two subunits, HA1 and HA2. target membrane bilayers. The energy required for stalk
Fusion mediated by this protein is triggered by a confor- formation is determined by the lipid composition of the
mational change in HA resulting in the exposure of a membranes. Thus, lipids with a large ratio of headgroup
hydrophobic ‘‘fusion peptide,’’ located at the N-terminus area to acyl chain cross-sectional area should inhibit
of the transmembrane subunit HA2 (Hughson, 1995; the formation of stalks, if they are present in the outer
Bentz, 1993), which is then inserted into the target mem- membrane leaflet (Chernomordik and Zimmerberg, 1995;
brane for fusion (Stegmann et al., 1991; Tsurudome et Chernomordik et al., 1995b). Indeed, lysophosphatidyl-
al., 1992) and thought to play a crucial role in initiating choline (LPC), a molecule with such an ‘‘inverted cone’’
fusion. shape, was found to inhibit a variety of biological mem-
Likewise, the N-terminus of gp41 is thought to function brane fusion events (Chernomordik et al., 1993, 1995a,c;
as a ‘‘fusion peptide’’ (Larsen et al., 1992; Freed and Mar- Yeagle et al., 1994; Vogel et al., 1993), and inhibition
of fusion appeared to be caused by inhibition of stalk
formation in those cases.1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 41-61-267-2189. E-mail: guenther@ubaclu.unibas.ch. However, we have previously investigated the effect
2 Abbreviations used: FCS, fetal calf serum; HA, hemagglutinin; HIV, of LPC on influenza virus-induced fusion (Gu¨nther-Aus-
human immunodeficiency virus; LPC, lysophosphatidylcholine; LPPC, born et al., 1995), and found that, in this case, LPC inhib-
lyso-1-palmitoyl-sn-3-phosphatidylcholine; LMPC, 1-myristoyl-sn-3-phos-
ited fusion at a step prior to the formation of lipid interme-phatidylcholine; LSPC, 1-stearoyl-sn-3-phosphatidylcholine; N-Rh-PE,
diates. The inhibitory effect was most likely caused by aN-(lissamine rhodamine B sulfonyl) phosphatidylethanolamine; PLA2 ,
phospholipase A2 ; SIV, simian immunodeficiency virus. direct interaction of the lysolipid with the hydrophobic
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fusion peptide of HA, preventing its insertion into the phenylalanin chloromethyl keton-treated trypsin (10 mg/
mL) for 5 min at 257 to convert the HA to its fusion-activetarget membrane.
Here, we have investigated the influence of LPC on form (Ellens et al., 1990). Proteolysis was stopped by
adding serum-containing medium. After 20 min at 377,cell–cell fusion mediated by the gp120/gp41 protein of
HIV-1. Fusion was inhibited only when LPC was added the medium was replaced by low pH buffer (135 mM
NaCl, 15 mM sodium citrate, 10 mM MES, 5 mM Hepes,from an aqueous stock solution and remained in the
buffer during the incubation. Since LPC either present in 1 mM CaCl2 , pH 4.8) for 3 min at 377 to induce fusion,
and the cells were then incubated at neutral pH in serum-the membrane after preincubation of cells with LPC or
produced after treatment of cellular membranes with free medium in the absence or presence of LPC at 377
for a further 2 to 3 hr. After several washes with PBS2/,phospholipase A2 (PLA2) did not affect fusion, it is con-
cluded that the lysolipid inhibits fusion because it pre- fixation with methanol, and staining with Giemsa, a num-
ber of cells and nuclei were counted. Fusion was quanti-vents specific cell–cell binding.
tated according to White et al. (1981): Fusion index  1
0 (number of cells/number of nuclei).MATERIALS AND METHODS
Materials PLA2 treatment
Cell culture media and fetal calf serum (FCS) were Prior to use, PLA2 was extensively dialyzed against 50
obtained from Gibco (Gibco BRL, Basel, Switzerland). Egg mM KCl (pH 8.0) to remove the ammonium sulfate (Ro-
LPC, lyso-1-palmitoyl-sn-3-phosphatidylcholine (LPPC), mero et al., 1987). Cells were treated with the enzyme
and N-(lissamine rhodamine B sulfonyl) phosphatidyleth- (about 140 mg/mL, specific activity 700 U/mg) for 15 to
anolamine (N-Rh-PE) were purchased from Avanti Polar 30 min at 377 in buffer (145 mM NaCl, 2.5 mM Hepes, 1
Lipids (Alabaster, AL). L-methionine sulfoximine, tosyl L- mM CaCl2) at pH 8.0. The reaction was terminated by
phenylalanin chloromethyl keton-treated trypsin, lyso-1- adding EDTA to 5 mM (final concentration). To determine
myristoyl-sn-3-phosphatidylcholine (LMPC), lyso-1-stear- the extent of phospholipid hydrolysis caused by PLA2 ,
oyl-sn-3-phosphatidylcholine (LSPC), and Triton X-100 CHO-gp160 cells were labeled by insertion of a fluores-
were obtained from Sigma. An ammonium sulfate sus- cent phospholipid analogue into the plasma membrane
pension of phospholipase A2 (PLA2) from porcine pan- as described by Kok et al. (1990). After the reaction, cellu-
creas was purchased from Boehringer-Mannheim. lar lipids were extracted according to Folch et al. (1957)
and separated on silica-coated glass plates with chloro-
Cell culture, binding, and syncytium assays form/methanol/25% ammonium hydroxide (70/30/5, v/v/
v). To quantify the fluorescence present in the various
gp120/gp41-expressing CHO K1 cells (CHO-gp160),
spots, relevant areas were scraped off from the plate
expressing the full-length env of the BH-10 strain of HIV-
and extracted with several volumes of chloroform/metha-
1 IIIB (Stephens and Cockett, 1989; Bebbington and
nol (1/1, v/v), and fluorescence was measured with a
Hentschel, 1987), and SupT1 cells (a human CD4 ex-
Jasco FP777 fluorimeter at an excitation wavelength of
pressing the T-lymphoblastic cell line) were grown as
560 nm and an emission wavelength of 590 nm.
described before (Frey et al., 1995). Fibroblasts stably
expressing HA (NIH-3T3 HAb-2) (Doxsey et al., 1985) Binding experiments
were grown in Dulbecco’s modified Eagle’s minimal es-
sential medium supplemented with 10% FCS and 2 mM To measure the binding of SupT1 to CHO-gp160 cells,
SupT1 cells were metabolically labeled with fluorescentL-glutamine. All media contained 100 U/mL penicillin and
100 mg/mL streptomycin. fatty acids as described before (Frey et al., 1995). Briefly,
cells were seeded at 1 1 105/mL in medium containingFor fusion induced by gp120/gp41, SupT1 cells (1 1
106) were added to 80–90% confluent CHO-gp160 cells 2 mg of the fatty acid 4,4-difluoro-5,5-dimethyl-4-bora-
3a,4a-diaza-3-indacene (BODIPY-FL C11, from Moleculargrown on 35-mm-diameter tissue culture dishes or, alter-
natively, 2.51 105 SupT1 cells were added to CHO-gp160 Probes, Eugene OR) per milliliter and grown for 3 days.
The cells were washed two times with PBS and incu-cells grown on coverslips. Samples were incubated in
medium for 3 to 5 hr at 377 in the absence or presence bated in fresh medium containing FCS to remove the
remaining nonmetabolized fatty acids. Coverslips withof LPC, washed with phosphate-buffered saline (PBS)
containing 1 mM Ca2/ and Mg2/, respectively (PBS2/), CHO-gp160 cells were placed in 24-well plates, overlaid
with 2.5 1 105 labeled SupT1 cells in the presence orto remove unbound SupT1 cells, fixed with ice-cold meth-
anol, and stained with Giemsa as described before (Frey absence of LPC and incubated for 3 to 5 hr at 377. After
extensive washing with PBS2/ to remove the unboundet al., 1995).
For syncytium formation by HA-expressing cells, 80– SupT1 cells, the remaining cells were lysed with 1% Tri-
ton X-100 and the fluorescence of BODIPY was measured90% confluent HAb-2 cells grown on 24- or 6-well tissue
culture plates were washed and pretreated with tosyl L- at an excitation wavelength of 495-nm and an emission
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effect on fusion, whereas in the presence of LMPC (14
carbon atoms) there was no effect on fusion up to 10
mM (Fig. 1). LPCs with shorter chains (e.g., hexyl- or
decyl-LPC) did not affect fusion at concentrations up to
20 mM (data not shown). Thus, as with influenza virus–
liposome fusion (Gu¨nther-Ausborn et al., 1995), inhibition
of gp120/gp41-induced cell–cell fusion by LPC in-
creased with increasing chain length. For comparison,
the effect of LPCs with different chain lengths on influ-
enza HA-induced cell–cell fusion was also determined,
as described under Materials and Methods. Syncytium
formation between HA-expressing cells was only slightly
affected by LMPC, whereas in the presence of LPPC or
LSPC fusion was drastically reduced, at about the same
concentrations that inhibited gp120/gp41 fusion (data not
shown). In conclusion, the chain length dependence of
inhibition of gp120/gp41- or HA-induced cell–cell fusion
FIG. 1. The inhibitory effect of LPC depends on the hydrocarbon
and HA-induced virus–liposome fusion was similar, sug-chain length. CHO-gp160 cells, grown on coverslips to 80–90% conflu-
gesting a similar inhibitory mechanism. However, for HA-ency, were overlaid with 2.51 105 SupT1 cells, and different concentra-
tions of egg LPC (dashed line), LMPC, LPPC, or LSPC were added induced cell–cell fusion, as a result of trypsin, low pH,
immediately. (Numbers in brackets denote the number of carbon atoms and LPC treatment (see Materials and Methods), many
in the acyl chain.) The cells were incubated in serum-free medium in HA-expressing cells had a rounded-up appearance, es-
the absence or presence of LPC for 3 hr. After washing with PBS2/,
pecially at higher concentrations of longer lysolipids, andthe cells were fixed with methanol and stained with Giemsa. A number
the decreased contact between cells probably contrib-of cells and nuclei was counted in several different fields of two cov-
erslips, and for each field a fusion index was calculated as described uted to the inhibition of fusion.
under Materials and Methods. The fusion indices were averaged; error
bars are 1 SD and reflect the difference in fusion indices between the
LPC present in the cell membranefields. At least 500 nuclei were counted per data point. Fusion indices
does not inhibit fusionare expressed as percentage of the control, obtained in the absence
of LPC.
When LPC is added to membranes from an aqueous
stock solution there are three different populations of the
wavelength of 512.5 nm. A 495-nm cutoff filter was placed lysolipid: monomeric and micellar LPC in the solution
between the sample and the emission monochromator to and membrane-associated LPC. If the latter causes inhi-
reduce light scattering. After fluorescence determination, bition of fusion, then preincubation of cells with LPC,
the protein concentration of the samples was measured. leading to its incorporation into the outer leaflet of the
Binding was calculated from the fluorescence per milli- membrane (De Kruijff et al., 1977; Bestermann and Do-
gram cell protein and expressed as a percentage of the manico, 1992), followed by removal of unincorporated
control, obtained in the absence of LPC. LPC, should also cause an inhibition of fusion. Thus,
CHO-gp160 cells were preincubated for 30 min at 377
RESULTS with 5 or 10 mM LPPC or LSPC, washed once with serum-
free medium and overlaid with SupT1 cells. Long chainExogenously added LPC inhibits fusion
LPCs like these are not extracted from membranes by
washing with buffer (Weltzien, 1979; Chernomordik et al.,CHO-gp160 cells, stably expressing the HIV glycopro-
tein gp120/gp41, are able to fuse with CD4-positive 1993); thus one can assume that after the wash a certain
percentage of lysolipid was still membrane-associated.SupT1 cells, resulting in the formation of large syncytia
(Frey et al., 1995). Fusion was inhibited when micromolar However, subsequent fusion of the cells with SupT1 cells
was not inhibited (Fig. 2), suggesting that the presenceamounts of egg LPC (mixed acyl chains, from egg yolk)
from an aqueous stock solution were added immediately of LPC in the medium during incubation of CHO-gp160
and SupT1 cells is a prerequisite for fusion inhibition.after mixing the CHO-gp160 cells with SupT1 cells (Fig.
1, dashed line). In the above experiment, it is difficult to estimate the
concentration of LPC remaining in the membrane. As anBecause inhibition of fusion in different biological sys-
tems was found to depend on the acyl chain length of alternative, cells were treated with PLA2 , an enzyme
which catalyzes the hydrolysis of the acyl chain from theLPC (Chernomordik et al., 1993, 1995c; Gu¨nther-Ausborn
et al., 1995), we tested a variety of LPC molecules for sn2 position of phospholipids, to produce lysophospho-
lipids and fatty acids in the membrane. Using fluores-their inhibitory activity on gp120/gp41-mediated cell–cell
fusion. LSPC (18 carbon atoms) showed the strongest cently labeled PE, this approach allowed us to establish
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does not inhibit fusion, and therefore, the monomeric or
micellar population of exogenously added LPC caused
the inhibitory effect.
The latter populations of LPC seemed to inhibit influ-
enza virus–liposome fusion by binding to the fusion pep-
tide of HA, preventing its interaction with the target mem-
brane (Gu¨nther-Ausborn et al., 1995). Therefore, if HA-
induced cell–cell fusion is inhibited in a similar fashion,
LPC produced by PLA2 should not inhibit fusion. In line
with these expectations, HA-induced cell–cell fusion
was not inhibited after PLA2 treatment of cells (Fig. 4).
Therefore, the inhibitory effect of LPC on both HA- and
gp120/gp41-induced fusion is caused by the monomeric
or micellar population and most likely involves lysolipid –
fusion protein interactions.
FIG. 2. Fusion after preincubation of cellular membranes with lysoli-
pids. CHO-gp160 cells, grown on coverslips, were preincubated in the
absence or presence of LPPC or LSPC for 30 min, 377. Subsequently, Exogenously added LPC inhibits cell–cell binding
the cells were washed once with serum-free medium and incubated
with 2.5 1 105 SupT1 cells for 3 hr. Fusion indices were determined The binding of neighboring cell membranes to each
as described in the legend to Fig. 1. Error bars are 1 SD. other necessarily precedes their fusion. We recently de-
veloped a fluorescence-based assay for the measure-
ment of cell–cell binding (Frey et al., 1995). Fluorescentthat PLA2 converted phospholipids, present in the outer
CD4 expressing cells, grown in suspension, are addedleaflet of the plasma membrane, into lysolipids. CHO-
to adherent gp120/gp41 expressing cells. After extensivegp160 cells were incubated with 5 mM (final concentra-
washing, the fluorescence remaining associated with thetion) fluorescent phospholipid analogue N-Rh-PE at 47
adherent cells is determined. This assay measures thefor 30 min, leading to its insertion into the plasma mem-
fluorescence of both bound and fused cells. However, inbrane of cells (Kok et al., 1990). After extensive washes
the presence or absence of an antibody against the V3to remove unincorporated N-Rh-PE, cells were incubated
loop of gp120, which inhibited cell–cell fusion but notfor 15 to 30 min with 100 U PLA2 in the presence of 1
binding, the same amount of fluorescence was found tomM Ca2/ at pH 8.0, 377. The reaction was stopped by
be associated with the adherent cells (Frey et al., 1995).adding 5 mM EDTA. The cellular lipids were then ex-
Thus, the assay can be used to quantitate cell–cell bind-tracted and separated by thin-layer chromatography and
ing. With this assay we measured binding of fluorescentthe fluorescence of N-Rh-PE and its hydrolysis product
was measured as described under Materials and Meth-
ods. In nontreated cells 81 { 3% of the fluorescence was
present in N-Rh-PE, and 19 { 3% was recovered as N-
Rh-lysoPE, in agreement with previous reports that a frac-
tion of cell-associated N-Rh-PE is rapidly degraded to
the lyso-form by cellular phospholipase (Kok et al., 1990).
However, after incubation with 100 U PLA2 , 93 { 1% had
been converted to N-Rh-lysoPE, and only 7 { 1% of total
fluorescence was present in N-Rh-PE, indicating that a
substantial fraction of the cellular lipids of the outer leaf-
let had been cleaved by the enzyme.
To test the effect of PLA2 treatment on fusion, CHO-
gp160 cells, grown on 35-mm tissue culture dishes, were
incubated with PLA2 as described above, and after re-
moval of the incubation buffer, cells were overlaid with
untreated SupT1 cells in serum-free medium. Alterna-
tively, SupT1 cells were incubated with 100 U PLA2 as FIG. 3. Lysolipids produced in the membrane do not inhibit fusion.
As indicated, either CHO-gp160 cells, grown on 35-mm tissue culturedescribed above, collected by centrifugation, resus-
dishes, or 1 1 106 SupT1 cells were incubated with 100 U PLA2 at pHpended in serum-free medium, and added to untreated
8.0 for 30 min at 377. The reaction was terminated by adding EDTA.CHO-gp160 cells. As shown in Fig. 3, PLA2 treatment of Subsequently, PLA2-treated cells were added to nontreated SupT1 oreither CHO-gp160 or SupT1 cellular membranes did not CHO-gp160 cells, respectively, and fusion was measured in serum-
inhibit fusion. Taken together, these data indicate that free medium as described in the legend to Fig. 1. In the control, neither
cell line was treated with PLA2 . Error bars are 1 SD.LPC present in the outer leaflet of cellular membranes
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tures (Wilschut and Hoekstra, 1986). Since LPC was
found to inhibit fusion events ranging from fusion induced
by viral proteins (Chernomordik et al., 1993, 1995c;
Yeagle et al., 1994), to cortical granule exocytosis (Vogel
et al., 1993; Chernomordik et al., 1993) and fusion be-
tween model membranes (Yeagle et al., 1994; Cherno-
mordik et al., 1995a), it was concluded that a step com-
mon to many fusion processes, like the formation of
these nonbilayer structures, is most likely affected (Cher-
nomordik et al., 1995c). The most plausible current model
for membrane fusion features lipid intermediates called
‘‘stalks,’’ which are hourglass-shaped structures com-
posed of fused outer but unfused inner leaflets of two
interacting membranes (Chernomordik et al., 1985;
Siegel, 1993a). The surface of the fused membrane leaflet
which forms the stalk has a net negative curvature. TheFIG. 4. LPC produced in HA-expressing cellular membranes does
not affect fusion. HA-expressing cells, grown on 35-mm tissue culture presence of LPC in the outer leaflet of contacting mem-
dishes, were pretreated with 10 mg/mL trypsin for 5 min, 257 followed branes should inhibit the formation of structures with
by an incubation in FCS-containing medium for 20 min, 377 as described negative curvature and therefore stalk formation (Cherno-
under Materials and Methods. Subsequently, cells were washed with
mordik et al., 1995b; Chernomordik and Zimmerberg,serum-free medium and incubated with or without (control) 100 U PLA2
1995). In accordance with this theory, LPC added to theat pH 8.0 for 30 min at 377. After low pH treatment (3 min, pH 4.8, 377),
cells were incubated in serum-free medium at neutral pH for 2 hr, 377. contacting leaflets of pure lipid membranes was found to
Fusion indices were determined as described in the legend to Fig. 1. inhibit fusion (Chernomordik et al., 1995a). Similar results
Error bars are 1 SD. were reported for baculovirus gp64-induced cell–cell fu-
sion: fusion was inhibited by LPC added exogenously or
SupT1 cells (labeled with BODIPY fatty acids as de-
scribed under Materials and Methods) to CHO-gp160
cells in the absence or presence of LPC. After removal
of unbound SupT1 cells by extensive washing with PBS2/
the remaining cells were lysed with 1% Triton X-100 in
PBS and the BODIPY fluorescence was measured. As
shown in Fig. 5, the gp120-CD4-specific cell–cell binding
was reduced in the presence of increasing concentra-
tions of LPCs with longer acyl chains, whereas LMPC
did not show an effect at concentrations up to 10 mM.
Within the range of concentrations tested, nonspecific
binding of SupT1 cells to CHO cells not expressing gp160
was not affected (Fig. 5). At any concentration of LPPC
fusion was more inhibited than binding; e.g., binding was
inhibited by about 20% in the presence of 5 mM LPPC,
whereas fusion was reduced by 50% at that concentra-
tion, indicating that there is an effects of LPPC beyond
the inhibition of binding. LSPC inhibited both binding
and fusion more strongly than LPPC, and there was no
difference between the effects on binding and fusion; FIG. 5. LPC inhibits cell–cell binding. CHO-gp160 cells, grown on
half-maximal inhibition of binding was found around 2 coverslips, were incubated with 2.5 1 105 fluorescent SupT1 cells in
the presence of different concentrations of LMPC, LPPC, or LSPC asmM, with 50% fusion being inhibited by 2.3 mM LSPC.
described in the legend to Fig. 1. After 3 hr, cells were washed severalTaken together, the above data indicate that LPC inhibits
times with PBS2/ and lysed with Triton X-100, and the fluorescencegp120/gp41-induced cell –cell fusion largely because it
was measured as described under Materials and Methods. Binding in
inhibits CD4-gp120-specific cell–cell binding and other the absence of LPC was set to 100% and binding in the presence of
interactions of the viral glycoprotein complex with the LPC was expressed as a percentage of this control. Note that the assay
measures the fluorescence of both bound but unfused SupT1 cells andhost cell membrane.
cells that were bound and had already fused with CHO-gp160 cells
(Frey et al., 1995). Nonspecific binding of SupT1 cells to CHO cellsDISCUSSION
not expressing gp120/gp41 was also measured. For comparison, the
The fusion of any two lipid bilayers requires the forma- dashed line represents fusion in the presence of LPPC (data from Fig.
1). Error bars are 1 SD.tion, at least locally and transiently, of nonbilayer struc-
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produced in the membrane by PLA2 treatment, sug- al., 1989; Kowalski et al., 1987; Freed et al., 1990, 1992;
Steffy et al., 1992; Martin et al., 1996).gesting that baculovirus fusion may proceed through
Therefore, one could speculate that LPC might inhibitthese intermediate structures. Therefore, inhibition of fu-
fusion induced by the HIV gp120/gp41 by a mechanismsion by LPC appeared to provide a useful indication of
similar to that by which LPC affects influenza fusion.the involvement of stalks as lipid intermediates.
Moreover, LPC could more subtly alter the interactionHowever, biological membrane fusion is always in-
between fusion peptides and target membranes, for ex-duced by fusion proteins (Stegmann et al., 1989), and
ample by affecting the orientation of this peptide in thetherefore the inhibitory effect of LPC could also be due
target membrane (Martin et al., 1993; Colotto et al., 1996).to lysolipid–fusion protein interactions. It is clear that
In this respect, it is interesting to note that fusion be-LPC inhibited gp120/gp41-mediated cell–cell fusion at
tween liposomes and the leakage of small moleculesthe level of specific cell–cell binding. The CD4 receptor,
from these liposomes, induced by synthetic peptideswhich is present on the SupT1 cells that we used as
corresponding to the N-terminal segment of HIV or SIV,targets, binds the gp120 subunit with high affinity, and
was inhibited also by (exogenous) LPC (Martin andthe initial binding event between the two molecules ap-
Ruysschaert, 1995).pears to involve a hydrophobic interaction between the
Experimental distinction between the two mechanismsCD4/CDR2 loop and a hydrophobic region of gp120
of inhibition (LPC–protein interactions and an effect on(Moore et al., 1993). Binding of LPC to hydrophobic bind-
lipid intermediate formation) is easiest if there are out-ing sites on gp120 or CD4 could block the sites, thus
spoken differences between the effect of LPC in solutionaffecting receptor–ligand interactions and, conse-
and that of membrane-associated LPC, as in this paper.quently, inhibit fusion. Moreover, recently the CD4 –
The chain length dependence of inhibition is more diffi-gp120 complex has been shown to associate with a
cult to evaluate. LPC inhibits the formation of negativelysecond receptor present in the membrane of the target
curved structures because its headgroup diameter iscell (Lapham et al., 1996). Although gp120 can interact
larger than its acyl chain diameter (inverted cone shape).with this second receptor in the absence of CD4, CD4
Therefore, if fusion is inhibited because stalk formationbinding greatly increases the affinity for the second re-
is inhibited, one would expect shorter LPCs, with a moreceptor (Wu et al., 1996; Trkola et al., 1996). Antibodies
pronounced inverted cone shape to more strongly affectcapable of neutralizing HIV, recognizing epitopes in the
fusion; this was indeed found in some cases (Cherno-V3 loop of gp120, were shown to block the interaction
mordik et al., 1993, 1995c). However, the difference in
with this second receptor (Wu et al., 1996; Trkola et al.,
shape is most pronounced for molecules with a chain
1996). Thus, it is also possible that LPC inhibits these
length of less than eight carbon atoms (Kumar, 1991),
interactions. However, at any concentration of LPPC fu-
and these did not inhibit fusion in most cases (Cherno-
sion was inhibited more strongly than binding, sug- mordik et al., 1993; Gu¨nther-Ausborn et al., 1995). On the
gesting that postbinding events also were influenced by other hand, HA- and gp120/gp41-induced fusion were
the monomeric and micellar population of LPC. inhibited by the monomeric or micellar populations of
Fusion of influenza virus with liposomes was inhibited LPC, but inhibition increased with increasing chain
by LPC at a step prior to the formation of lipid intermedi- length. In the presence of membranes, longer chain LPCs
ates (Gu¨nther-Ausborn et al., 1995). In this case, LPC partition more easily into the membranes, and therefore
inhibited binding of the virus to zwitterionic membranes the concentration of LPC in the solution decreases with
at low pH, and it inhibited the leakage of small molecules increasing chain length (Brown et al., 1993). Thus, one
from liposomes, both of which are induced by the interac- has to assume that hydrophobic sites in proteins prefer-
tion of the fusion peptide of HA with the target membrane. entially bind to longer, more hydrophobic LPCs. Similar
However, fusion peptide insertion into membranes con- observations were made for the binding of LPC to bovine
taining LPC was still possible (Gu¨nther-Ausborn et al., serum albumin via hydrophobic interactions (Brown et
1995). These data seemed to suggest that the hydropho- al., 1993).
bic part of LPC binds to the hydrophobic fusion peptide, The reported concentrations of LPC required for inhibi-
and if this is covered with LPC it can no longer insert tion of cell–cell fusion induced by baculovirus gp64 were
into the target membrane. Shangguan et al. (1996) also about 10-fold higher than those needed for inhibition of
found that HA-mediated fusion was inhibited by LPC and HIV or influenza fusion (Chernomordik et al., 1995c; see
suggested that LPC–HA interactions could be affected, also published erratum). Differences in experimental set-
rather than lipid intermediates. up and type of cells (insect vs mammalian cells) could
HIV and simian immunodeficiency virus (SIV) appear be responsible for the difference. However, it is also
to have fusion peptides at the N-terminus of their trans- possible that these differences are related to differences
membrane protein (Larsen et al., 1992; Freed and Martin, in hydrophobicity of the sites in gp120/gp41 and the HA
1995). Mutations in these peptides affected the fusion fusion peptide on the one hand and hydrophobic sites
in gp64 on the other.capacity of these proteins (Felser et al., 1989; Bosch et
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E. A., and Zimmerberg, J. (1993). Lysolipids reversibly inhibit Ca2/-,In conclusion, LPC did not inhibit fusion mediated by
GTP- and pH-dependent fusion of biological membranes. FEBS Lett.the HIV gp120/gp41 because it prevented the formation
318, 71–76.
of lipid intermediates, but seemed to act at an earlier Chernomordik, L. V., and Zimmerberg, J. (1995). Bending membranes
stage, as we have found previously for the influenza virus to the task: Structural intermediates in bilayer fusion. Curr. Opin.
Struct. Biol. 5, 541–547.HA. But since LPC inhibition of fusion acts at an early
Colotto, A., Martin, I., Ruysschaert, J.-M., Sen, A., Hui, S. W., and Epand,stage of the fusion process, we cannot exclude that lipid
R. M. (1996). Structural study of the interaction between the SIV fusionintermediates would be inhibited, if they were formed.
peptide and model membranes. Biochemistry 35, 980–999.
The data presented in this paper show that inhibition De Kruijff, B., Van den Besselaar, A. M. H. P., and Van Deenen, L. L. M.
was caused by nonmembrane-bound LPC which affected (1977). Outside-inside distribution and translocation of lysophospha-
tidylcholine vesicles as determined by 13C-NMR using (N-13CH3)-the interactions of the viral fusion protein with the target
enriched lipids. Biochim. Biophys. Acta 465, 443–453.membrane. In addition to a direct effect on the gp120 –
Doxsey, S., Sambrook, J., Helenius, A., and White, J. (1985). An efficienthost cell interaction, the postbinding effects, observed
method for introducing macromolecules into living cells. J. Cell Biol.
with LPPC, could be interpreted to suggest a direct inter- 101, 19–27.
action of the lysolipid with the putative fusion peptide of Ellens, H., Bentz, J., Mason, D., Zhang, F., and White, J. (1990). Fusion
of influenza hemagglutinin-expressing fibroblasts with glycophorin-gp41. Such interactions between LPC and hydrophobic
bearing liposomes: Role of hemagglutinin surface density. Biochem-parts of fusion proteins could also play a role in other
istry 29, 9697–9707.biological fusion events and have to be distinguished
Felser, J. M., Klimkait, T., and Silver, J. (1989). A syncytic assay for
from the effect of LPC on the formation of fusion interme- human immunodeficiency virus envelope protein and its use in study-
diates. ing HIV-1 mutations. Virology 170, 566–570.
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